H-alpha-Me-L-Asp(tBu)-OH

H-alpha-Me-L-Asp(tBu)-OH is an L-aspartic acid derivative featuring an α-methyl substitution at the amino acid backbone and a tert-butyl ester on the side-chain carboxyl group. The structure contains a stereogenic center at the α-position consistent with L-configuration and a second stereogenic element is not introduced beyond the α-carbon, while the side-chain is masked as a carboxyl protecting group that modulates polarity and coupling behavior. The amino acid acid functionality and the protected side-chain carboxyl enable controlled peptide coupling chemistry, while the α-methyl group can influence conformational preference and steric access during amide bond formation. The combination of an α-substituted backbone and a tert-butyl-protected side chain positions the compound as a chiral synthetic intermediate for peptide building block preparation and downstream functionalization of aspartate-derived motifs.

1. Protected Aspartate Peptide Synthesis

H-alpha-Me-L-Asp(tBu)-OH is applied in peptide synthesis workflows where aspartate side-chain protection and α-substitution must be maintained through coupling steps. The molecule presents a free α-carboxylic acid and an L-configured α-amino acid framework, while the side-chain carboxyl is protected as a tert-butyl ester that can be selectively removed under acidolytic conditions compatible with peptide assembly. The α-methyl substituent can improve stereochemical control in amide bond formation by altering steric approach and can be used to generate peptide analogs with modified backbone geometry. The protected aspartate motif supports sequential N- and C-terminal peptide construction and enables preparation of Asp-containing sequences for structural studies and synthetic methodology development.

2. Peptidomimetic And SAR Studies

H-alpha-Me-L-Asp(tBu)-OH serves in peptidomimetic construction and structure-activity relationship studies where conformational tuning around the aspartate residue is required. The α-methyl substitution provides a handle for generating backbone-restricted analogs, while the tert-butyl-protected side-chain carboxyl allows late-stage deprotection to reveal the anionic functionality for receptor-binding or electrostatic interaction mapping. The protected carboxyl group can participate in controlled derivatization strategies after deprotection, including salt formation, amide formation, or coupling to linkers used in SAR panels. The resulting aspartate analogs can be incorporated into larger scaffolds to probe how stereochemistry and side-chain presentation influence molecular recognition.

3. Side-Chain Carboxyl Derivatization

H-alpha-Me-L-Asp(tBu)-OH is suitable for amino acid derivatization programs targeting the aspartate side-chain carboxyl chemistry with protection-managed reactivity. The tert-butyl ester masking reduces undesired side reactions during peptide coupling or intermediate transformations, and subsequent deprotection can regenerate the side-chain carboxylic acid for selective functional group conversion. The free α-carboxyl group and the L-amino acid stereochemistry enable formation of amide-linked intermediates and attachment of the residue to polymer backbones, linkers, or scaffold fragments in a controlled sequence. Downstream products may include functionalized aspartate derivatives used for materials chemistry, affinity reagent construction, or chemical biology probes requiring a defined acidic group geometry.

4. Chemical Biology Conjugation

H-alpha-Me-L-Asp(tBu)-OH is utilized in chemical biology workflows that require incorporation of an aspartate-based motif into conjugates with defined stereochemistry and masked functional groups. The protected side-chain carboxyl helps manage chemoselectivity during linker installation, while the α-substituted backbone can be retained to preserve the steric and conformational characteristics of the residue within a larger biomolecular construct. The molecule can be converted into coupling-ready derivatives for attaching to peptides, proteins, or nucleic-acid-associated scaffolds through amide bond formation or carboxyl-activated conjugation strategies. The stereodefined aspartate unit supports generation of labeled or functionalized biomolecule analogs used in binding studies, pathway mapping, and probe design.

5. Pharmaceutical Intermediate Preparation

H-alpha-Me-L-Asp(tBu)-OH is relevant to pharmaceutical intermediate preparation where protected amino acid building blocks are required for controlled assembly of peptide-like fragments. The tert-butyl-protected side-chain carboxyl group functions as a protection strategy that can be carried through steps that require compatibility with coupling reagents and subsequent deprotection to expose the reactive carboxyl functionality at the appropriate stage. The α-methyl substitution provides a route to chiral, backbone-modified aspartate units that can be incorporated into drug discovery libraries of constrained amino acid analogs and peptidomimetic fragments. The compound's defined stereochemistry and protected-group architecture support process-oriented synthesis of intermediates for fine chemical manufacturing and downstream structure elaboration.

6. Process Chemistry For Chiral Building Blocks

H-alpha-Me-L-Asp(tBu)-OH is employed in process chemistry contexts focused on scalable production of chiral amino acid intermediates for peptide building block preparation. The L-configuration at the α-center and the stable tert-butyl ester protecting group enable manufacturing routes that separate protection, coupling, and deprotection stages to manage reactivity and impurity profiles. The α-methyl substitution can be leveraged to produce consistent stereochemical outcomes in protected amino acid synthesis and to generate reproducible peptide analog intermediates for subsequent manufacturing steps. The compound's functional group pattern supports integration into industrial fine chemical synthesis pipelines that require chiral, protected amino acid derivatives compatible with peptide coupling chemistry and controlled downstream transformations.

1. Cationic cell-penetrating peptides are potent furin inhibitors

2. C-peptide and its C-terminal fragments improve erythrocyte deformability in type 1 diabetes patients

3. Characterization of Novel P-Selectin Targeted Complement Inhibitors in Murine Models of Hindlimb Injury and Transplantation

4. The effect of B-type allatostatin neuropeptides on crosstalk between the insect immune response and cold tolerance

5. Store-operated Ca2+ entry sustains the fertilization Ca2+ signal in pig eggs